Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the treatment of COVID-19. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. It has research and license agreements with AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. The company also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases, as well as other non-central nervous system (non-CNS) disease development candidates. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.
Unternehmen & Branche
| Name | RIGEL PHARMACEUTICALS INC |
|---|---|
| Ticker | RIGL |
| CIK | 0001034842 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 766559603 |
|---|---|
| ISIN | US7665596034 |
| Typ | Common Stock |
| Marktkapitalisierung | 538,5 Mio. USD |
| Beta | 1,27 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 294,282,000 | 367,024,000 | 19.48 | 513,594,000 | 391,480,000 |
| 2025-09-30 | 10-Q | 69,462,000 | 27,900,000 | 1.46 | 242,534,000 | 117,609,000 |
| 2025-06-30 | 10-Q | 101,685,000 | 59,613,000 | 3.28 | 206,736,000 | 81,934,000 |
| 2025-03-31 | 10-Q | 53,333,000 | 11,446,000 | 0.63 | 175,972,000 | 18,567,000 |
| 2024-12-31 | 10-K | 179,278,000 | 17,485,000 | 0.99 | 163,976,000 | 3,288,000 |
| 2024-09-30 | 10-Q | 55,307,000 | 12,421,000 | 0.70 | 139,419,000 | -14,636,000 |
| 2024-06-30 | 10-Q | 36,841,000 | -1,030,000 | -0.06 | 128,408,000 | -29,914,000 |
| 2024-03-31 | 10-Q | 29,534,000 | -8,247,000 | -0.47 | 126,519,000 | -31,671,000 |
| 2023-12-31 | 10-K | 116,882,000 | -25,091,000 | -1.44 | 117,225,000 | -28,644,000 |
| 2023-09-30 | 10-Q | 28,134,000 | -5,692,000 | -0.33 | 115,324,000 | -31,834,000 |
| 2023-06-30 | 10-Q | 26,886,000 | -6,600,000 | -0.38 | 117,091,000 | -28,115,000 |
| 2023-03-31 | 10-Q | 26,070,000 | -13,536,000 | -0.08 | 123,612,000 | -24,257,000 |
| 2022-12-31 | 10-K | 120,242,000 | -58,573,000 | -3.44 | 134,279,000 | -13,616,000 |
| 2022-09-30 | 10-Q | 22,410,000 | -19,037,000 | -0.11 | 115,609,000 | -19,834,000 |
| 2022-06-30 | 10-Q | 29,819,000 | -13,492,000 | -0.08 | 128,001,000 | -3,677,000 |
| 2022-03-31 | 10-Q | 16,735,000 | -27,445,000 | -0.16 | 149,074,000 | 6,798,000 |
| 2021-12-31 | 10-K | 149,236,000 | -17,914,000 | -0.11 | 167,328,000 | 30,374,000 |
| 2021-09-30 | 10-Q | 21,543,000 | -20,952,000 | -0.12 | 186,518,000 | 49,670,000 |
| 2021-06-30 | 10-Q | 26,266,000 | -13,821,000 | -0.08 | 201,598,000 | 68,110,000 |
| 2021-03-31 | 10-Q | 81,018,000 | 39,500,000 | 0.22 | 215,993,000 | 78,298,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 1,664,210 | 0 | 1,664,210 | 71,278,114 | Neu | +100,0% | |
| STATE STREET CORP | 1,091,223 | 0 | 1,091,223 | 46,737,081 | Neu | +100,0% | |
| VANGUARD GROUP INC | 1,038,408 | 0 | 1,038,408 | 44,475,015 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 671,878 | 0 | 671,878 | 28,776,535 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 613,600 | 0 | 613,600 | 26,280,489 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 539,009 | 0 | 539,009 | 23,085,755 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 431,460 | 0 | 431,460 | 18,479,432 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 424,314 | 0 | 424,314 | 18,177,612 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 424,316 | 0 | 424,316 | 18,173,454 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 413,659 | 0 | 413,659 | 17,717,015 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 312,883 | 0 | 312,883 | 13,400,779 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 300,034 | 0 | 300,034 | 12,850,456 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 288,269 | 0 | 288,269 | 12,346,561 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 276,812 | 0 | 276,812 | 11,855,857 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 271,228 | 0 | 271,228 | 11,616,695 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 254,492 | 0 | 254,492 | 10,899,892 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 242,119 | 0 | 242,119 | 10,369,957 | Neu | +100,0% | |
| CM Management, LLC | 225,000 | 0 | 225,000 | 9,636,750 | Neu | +100,0% | |
| GLOBEFLEX CAPITAL L P | 217,839 | 0 | 217,839 | 9,330,044 | Neu | +100,0% | |
| Trexquant Investment LP | 197,148 | 0 | 197,148 | 8,443,849 | Neu | +100,0% | |
| MORGAN STANLEY | 166,489 | 0 | 166,489 | 7,130,765 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 148,636 | 0 | 148,636 | 6,366,080 | Neu | +100,0% | |
| PRUDENTIAL FINANCIAL INC | 135,428 | 0 | 135,428 | 5,800,381 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 130,781 | 0 | 130,781 | 5,601,350 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 129,022 | 0 | 129,022 | 5,526,011 | Neu | +100,0% | |
| ZACKS INVESTMENT MANAGEMENT | 119,088 | 0 | 119,088 | 5,100,534 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 116,952 | 0 | 116,952 | 5,009,053 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 109,736 | 0 | 109,736 | 4,699,993 | Neu | +100,0% | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 107,989 | 0 | 107,989 | 4,625,169 | Neu | +100,0% | |
| Connor, Clark & Lunn Investment Management Ltd. | 107,969 | 0 | 107,969 | 4,624,312 | Neu | +100,0% | |
| RITHOLTZ WEALTH MANAGEMENT | 80,593 | 0 | 80,593 | 3,451,798 | Neu | +100,0% | |
| Empire Financial Management Company, LLC | 76,445 | 0 | 76,445 | 3,274,139 | Neu | +100,0% | |
| BARCLAYS PLC | 75,359 | 0 | 75,359 | 3,227,625 | Neu | +100,0% | |
| Brandywine Global Investment Management, LLC | 71,570 | 0 | 71,570 | 3,065,343 | Neu | +100,0% | |
| FMR LLC | 67,838 | 0 | 67,838 | 2,905,504 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 61,999 | 0 | 61,999 | 2,655,417 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 57,001 | 0 | 57,001 | 2,441,354 | Neu | +100,0% | |
| Man Group plc | 56,688 | 0 | 56,688 | 2,427,947 | Neu | +100,0% | |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 55,200 | 0 | 55,200 | 2,364,216 | Neu | +100,0% | |
| Squarepoint Ops LLC | 53,556 | 0 | 53,556 | 2,293,803 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 52,982 | 0 | 52,982 | 2,269,219 | Neu | +100,0% | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 66,060 | 0 | 66,060 | 2,088,817 | Neu | +100,0% | |
| UBS Group AG | 46,438 | 0 | 46,438 | 1,988,940 | Neu | +100,0% | |
| Range Financial Group LLC | 45,938 | 0 | 45,938 | 1,967,525 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 44,487 | 0 | 44,487 | 1,905,378 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 43,755 | 0 | 43,755 | 1,874,027 | Neu | +100,0% | |
| Advisory Services Network, LLC | 43,666 | 0 | 43,666 | 1,870,215 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 41,023 | 0 | 41,023 | 1,757,015 | Neu | +100,0% | |
| Ruffer LLP | 37,244 | 0 | 37,244 | 1,597,533 | Neu | +100,0% | |
| SEGALL BRYANT & HAMILL, LLC | 37,256 | 0 | 37,256 | 1,595,674 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BlackRock, Inc. | 1,664,210 | 71,278,114 | 12.88 |
| STATE STREET CORP | 1,091,223 | 46,737,081 | 8.45 |
| VANGUARD GROUP INC | 1,038,408 | 44,475,015 | 8.04 |
| GOLDMAN SACHS GROUP INC | 671,878 | 28,776,535 | 5.20 |
| MARSHALL WACE, LLP | 613,600 | 26,280,489 | 4.75 |
| RENAISSANCE TECHNOLOGIES LLC | 539,009 | 23,085,755 | 4.17 |
| MILLENNIUM MANAGEMENT LLC | 431,460 | 18,479,432 | 3.34 |
| GEODE CAPITAL MANAGEMENT, LLC | 424,314 | 18,177,612 | 3.29 |
| D. E. Shaw & Co., Inc. | 424,316 | 18,173,454 | 3.29 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 413,659 | 17,717,015 | 3.20 |
| JANE STREET GROUP, LLC | 312,883 | 13,400,779 | 2.42 |
| Soleus Capital Management, L.P. | 300,034 | 12,850,456 | 2.32 |
| Qube Research & Technologies Ltd | 288,269 | 12,346,561 | 2.23 |
| DIMENSIONAL FUND ADVISORS LP | 276,812 | 11,855,857 | 2.14 |
| TWO SIGMA INVESTMENTS, LP | 271,228 | 11,616,695 | 2.10 |
| AMERICAN CENTURY COMPANIES INC | 254,492 | 10,899,892 | 1.97 |
| CITADEL ADVISORS LLC | 242,119 | 10,369,957 | 1.87 |
| CM Management, LLC | 225,000 | 9,636,750 | 1.74 |
| GLOBEFLEX CAPITAL L P | 217,839 | 9,330,044 | 1.69 |
| Trexquant Investment LP | 197,148 | 8,443,849 | 1.53 |